MKS Instruments, Inc. — Form 10-Q Summary
Reporting period: Quarter ended September 30, 2022; filed November 7, 2022. Unaudited results are in U.S. dollars, in millions except per-share amounts. MKS supplies technologies and specialty chemicals for semiconductor manufacturing, advanced electronics, and specialty industrial markets. The quarter includes Atotech results from its August 17 acquisition date.
Financial results and liquidity
| Metric | Q3 2022 | Comparison |
|---|---|---|
| Revenue | $954 | +$212 (+29%) year over year; +$189 (+25%) from Q2 |
| Gross profit / margin | $390 / 40.8% | Margin: 46.9% in Q3 2021; 44.2% in Q2 2022 |
| Operating income / margin | $118 / 12.5% | $175 / 23.7% in Q3 2021; $164 / 21.4% in Q2 2022 |
| Net income / diluted EPS | $6 / $0.09 | $132 / $2.38 in Q3 2021 |
| Interest expense | $80 | $6 in Q3 2021; primarily reflects acquisition financing |
For the nine months ended September 30, revenue was $2,461, up 13% year over year; net income was $279 versus $401, and operating cash flow was $345 versus $445. Diluted EPS for the nine months was $4.84 versus $7.21.
At September 30, cash and cash equivalents were $884; current assets were $2,791 and current liabilities $1,011. Inventory rose to $961 from $577 at year-end 2021. Debt carrying value was $4,988, including $95 short-term and $4,893 long-term; term-loan principal was approximately $5.2 billion, at a 5.6% weighted-average interest rate. No revolving-facility borrowings were outstanding; $500 million of commitments were available. The company reported covenant compliance.
Nine-month investing cash outflow was $4.5 billion, principally the Atotech acquisition and $109 of capital expenditures. Financing cash inflow was $4.1 billion, reflecting new term-loan proceeds, offset in part by debt repayments and $37 of dividends. Operating cash flow was reduced by working-capital investment, particularly a $188 inventory increase.
Material changes and drivers
- Atotech was acquired for preliminary net purchase consideration of $5.664 billion, funded with cash, debt, and 10.7 million newly issued MKS shares. It contributed $177 of revenue and a $44 net loss since acquisition. Purchase accounting remains preliminary; acquired goodwill was $2.720 billion and acquired intangible assets $3.251 billion.
- Reported Q3 growth includes Atotech and is not a like-for-like comparison. Semiconductor revenue was $541, advanced electronics $185, and specialty industrial $228. Atotech added $177 of reported segment revenue; it was included in advanced electronics and specialty industrial markets.
- Gross margin fell sequentially and year over year, with management citing component shortages, higher materials and logistics costs, and weaker manufacturing overhead absorption. A preliminary $89 inventory fair-value step-up from Atotech resulted in $39 of Q3 amortization, with the remainder expected in Q4.
- Q3 operating income was also affected by higher acquisition/integration costs ($31) and intangible amortization ($47). Interest expense rose sharply following acquisition financing. A one-time $30 tax charge related to changing the indefinite-reinvestment assertion contributed to the 85.5% quarterly effective tax rate.
- Foreign-currency translation reduced Q3 comprehensive income by $227; total comprehensive loss was $168.
Outlook, risks, and contingencies
- No broad revenue or earnings guidance is stated in the provided filing text. Management said supply constraints were expected to continue in the near term.
- Following October 2022 U.S. BIS export-control rules, MKS preliminarily estimated an annualized revenue reduction of $250–$350 million, primarily affecting semiconductor-related sales to China. The company cautioned that the impact could be greater and was still assessing the rules.
- Management highlighted substantial post-acquisition leverage, variable interest-rate exposure, integration and synergy execution, and possible goodwill or intangible impairment. Approximately 50% of term-loan principal was covered by interest-rate hedges; a 10% rate change was estimated to affect annual interest expense by about $16 million net of hedges.
- Other significant risks include semiconductor and electronics demand cyclicality, supply-chain and component constraints, customer concentration (Lam Research represented 15% and Applied Materials 10% of Q3 revenue), China and international trade restrictions, and Atotech’s chemical-manufacturing, environmental, and regulatory exposures. The filing identifies PFAS-related litigation and regulatory matters as risks; it does not provide a clear quantified exposure.
- The company reported $95 of Atotech purchase commitments, mostly for less than one year. The Nevada shareholder litigation related to the Newport acquisition was affirmed in the company’s favor in March 2022; management said other ordinary-course proceedings were not expected to have a material adverse effect.
Important facts for investors to verify
- Atotech’s final purchase-price allocation, integration costs, operating contribution, and progress toward anticipated benefits.
- The actual revenue and margin impact of the BIS restrictions, especially relative to the preliminary $250–$350 million annualized estimate.
- Debt reduction, cash generation, interest costs, leverage-covenant headroom, and the effect of floating rates as scheduled repayments begin.
- Whether supply constraints and inventory levels improve, and whether product margins recover after inventory step-up amortization ends.
- Any material developments in chemical, environmental, PFAS, tax, or other legal contingencies and related financial exposure.